Zentek Corp (ZTEK): Rasio kapitalisasi pasar marang pendapatan

Simbol lan logo merek Zentek Limited (ZTEK)

Zentek Ltd. faces a prolonged market rollout of its graphene products and stringent FDA oversight. The company's average P/S reflects revenue valuation volatility, with the parameter stabilizing at 779.70. Business growth relies on licensing patents to third-party firms. Success is driven by leading materials scientists, who are retained through unique developments and stock options.

Rasio rega marang pendapatan: Zentek (ZTEK) kanggo 28.04.2023 - 12.09.2026

Rincian metrik lan analitis perusahaan Zentek (ZTEK)

- kuotasi lan prakiraan analis:
Ringkesan analitik perusahaan:Zentek Ltd
Produk seri zentek.com

Zentek Ltd. focuses its development on the implementation of nanocoatings, which renders the company's revenue volatile during the early stages of commercialization. The P/S ratio correlates the business's market value with its actual sales volume, allowing for an assessment of the value of a single dollar of revenue. By analyzing the P/S chart, an investor can observe the dynamics of market expectations relative to sector medians. Sharp spikes in the curve signal a potential overvaluation of capitalization amid speculative optimism.

Pesaing Zentek Ltd.

Kapitalisasi marang volume dodolan ISRG|Danaher Corporation - Kapitalisasi marang pendapatan|Multiplikator P/S Becton Dickinson & Company BDX|STE - Rasio rega marang pendapatan|West Pharmaceutical Services (WST) - Kapitalisasi marang pendapatan|BAX: Multiplikator P/S|Kapitalisasi marang pendapatan Masimo|STVN (stevanatogroup.com) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan TFX (Teleflex Incorporated)|Rasio rega marang pendapatan Merit Medical (MMSI)|Envista - Rasio kapitalisasi marang pendapatan|ICU Medical, Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan XRAY (Dentsply Sirona Inc)|LMAT - Rasio rega marang pendapatan|Koefisien rega marang pendapatan AtriCure Corp ATRC|staar.com (STAA) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan ChromaDex Corporation|ZIMV (ZimVie Inc) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan ANGO (AngioDynamics)|Rasio rega marang pendapatan Cerus Corp (CERS)|TKNO: Rasio rega marang dodolan|Rasio rega marang pendapatan Monogram Technologies Inc. MGRM|Rasio kapitalisasi pasar marang pendapatan STSS|INFU - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan UTMD (Utah Medical Products Inc.)|KORU Medical Systems Inc. (KRMD) - Rasio rega marang pendapatan|Nyxoah S.A. - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Microbot Medical, Inc.|Rasio kapitalisasi marang pendapatan PDEX (Pro-Dex)|Multiplikator P/S ELUT|Milestone Scientific Inc. - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan NEXGEL, Inc. NXGL|Retractable Tech - Rasio rega marang pendapatan|harvardbioscience.com - Multiplikator P/S|FEMY (Femasys Inc.) - Rasio kapitalisasi marang pendapatan|MHUA: Multiplikator P/S|Predictive Oncology Corp - Rasio kapitalisasi pasar marang pendapatan|CJMB (Callan JMB) - Multiplikator P/S|Rega marang dodolan Atrion Corporation Inc. ATRI|Multiplikator P/S NURO